Glaucoma Epidemiology Analysis and Forecast to 2033
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Glaucoma Report Overview
In the 7MM, there were 4,190,943 diagnosed incident cases of primary open-angle glaucoma (POAG) excluding NTG in 2023. The diagnosed incident cases of glaucoma will register an AGR of more than 1% during 2023-2033. Glaucoma is a group of progressive neurodegenerative eye diseases caused by damage to the optic nerve. Glaucoma has a major effect on quality of life and is the primary cause of blindness and vision loss worldwide. It is categorized as primary open-angle glaucoma (POAG), normal tension glaucoma (NTG), primary angle-closure glaucoma (PACG), chronic angle-closure glaucoma, acute angle-closure glaucoma, and secondary glaucoma.
Primary Open-Angle Glaucoma (POAG) excluding NTG Market Outlook, 2023-2033 (Diagnosed Incident Cases)
Buy the Full Report for More Insights into the Glaucoma Market Forecast
The glaucoma market research report provides an overview of the risk factors and the global and historical epidemiological trends for glaucoma in the eight major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). Additionally, this report includes a 10-year epidemiological forecast for the diagnosed incident cases of glaucoma and five-year diagnosed prevalent cases of glaucoma. The diagnosed incident cases are segmented by age (18 years and older) and sex.
| Market Size (2023) | 4,190,943 Cases |
| AGR (2023-2033) | >1% |
| Forecast Period | 2023-2033 |
| Key Countries | · The US
· France · Germany · Spain · Italy · The UK · Japan |
| Key Sex Segments | · Men
· Women |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Glaucoma Market Segmentation by Country
The key countries across the 7MM are the US, France, Germany, Spain, Italy, the UK, and Japan. In 2023, the US accounted for the highest percentage of diagnosed incident cases of glaucoma in the 7MM. Changes in diagnosed prevalent cases are attributable to changing population demographics and moderately increasing prevalence across markets.
Glaucoma Market Analysis by Country, 2023 (%)
Buy the Full Report for More Country Insights into the Glaucoma Market
Download a Free Report Sample
Glaucoma Market Segmentation by Sex
Based on sex, the market can be segmented into men and women. In 2023, the diagnosed incident cases of glaucoma in the 7MM were higher in women than men. Among the 7MM, France had the largest differences in the diagnosed incident cases of glaucoma in men and women.
Glaucoma Market Analysis by Sex, 2023 (%)
Buy the Full Report for More Sex Insights into the Glaucoma Market
Segments Covered in the Report
Glaucoma Market Country Outlook (Diagnosed Incident Cases)
- The US
- France
- Germany
- Spain
- Italy
- The UK
- Japan
Glaucoma Market Sex Outlook (Diagnosed Incident Cases)
- Men
- Women
Scope
- The glaucoma epidemiology report provides an overview of the risk factors, comorbidities, and global and historical epidemiological trends for glaucoma in the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan). The report includes a 10-year epidemiology forecast for the diagnosed prevalent cases of POAG and PACG, segmented by age and sex (40–44 years, 45–49 years, 50–54 years, 55–59 years, 60–64 years, 65–69 years, 70–74 years, 75–79 years, 80–84 years, and ≥85 years) in the 7MM.
- Additionally, this report provides a 10-year epidemiology forecast of the diagnosed prevalent cases of the clinical types of glaucoma: NTG, acute and chronic PACG, secondary glaucoma, and the diagnosed incident cases of PACG. Although not covered in this report, the diagnosed prevalence of pigmentary glaucoma and pseudo-exfoliation glaucoma can be found in the associated glaucoma model, as well as the total prevalence of POAG (excluding NTG) and PACG.
- In the 7MM, the diagnosed prevalent cases of POAG (including NTG) are expected to increase in 2033. POAG is the predominant clinical subtype of glaucoma in all markets.
Reasons to Buy
The glaucoma epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global glaucoma markets.
- Quantify patient populations in the global glaucoma markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for glaucoma therapeutics in each of the markets covered.
- Understand magnitude of the glaucoma population by age, sex, type, and infection site.
Table of Contents
Table
Figures
Frequently asked questions
-
How many diagnosed incident cases of glaucoma were seen in the 7MM in 2023?
In 2023, there were 4,190,943 diagnosed incident cases of glaucoma in the 7MM.
-
What will the growth rate of the glaucoma market be during the forecast period?
The diagnosed incident cases of glaucoma will register an AGR of more than 1% during 2023-2033.
-
Which was the leading sex segment in the glaucoma market in 2023?
In 2023, the number of diagnosed incident cases of glaucoma was higher in women in the 7MM combined.
-
Which country had the largest differences in the diagnosed incident cases of glaucoma among the 7MM?
Among the 7MM, France had the largest differences in the diagnosed incident cases of glaucoma in men and women.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Glaucoma reports


